| SC 13G/A | 2024-04-01 | LEVIN CAPITAL STRATEGIES, L.P. | Gamida Cell Ltd. | 3,747,630 | 2.4% | EDGAR |
| SC 13G/A | 2024-02-14 | CVI Investments, Inc. | Gamida Cell Ltd. | 6,966,279 | 4.9% | EDGAR |
| SC 13G/A | 2024-02-14 | Rock Springs Capital Management LP | Gamida Cell Ltd. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-13 | Stonepine Capital Management, LLC | Gamida Cell Ltd. | 3,000,000 | 2.2% | EDGAR |
| SC 13G/A | 2024-02-09 | FMR LLC | Gamida Cell Ltd. | 9,408,902 | 7.0% | EDGAR |
| SC 13G | 2024-02-08 | LEVIN CAPITAL STRATEGIES, L.P. | Gamida Cell Ltd. | 9,128,376 | 6.9% | EDGAR |
| SC 13G/A | 2024-02-02 | HIGHBRIDGE CAPITAL MANAGEMENT LLC | Gamida Cell Ltd. | 4,222,973 | 3.1% | EDGAR |
| SC 13D/A | 2023-11-20 | AI Gamida Holdings LLC | Gamida Cell Ltd. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2023-11-08 | Community US Fund Management, Inc. | Gamida Cell Ltd. | 6,169,471 | 4.7% | EDGAR |
| SC 13D/A | 2023-10-02 | AI Gamida Holdings LLC | Gamida Cell Ltd. | 3,750,000 | 2.9% | EDGAR |
| SC 13G | 2023-08-24 | Stonepine Capital Management, LLC | Gamida Cell Ltd. | 9,854,158 | 7.9% | EDGAR |
| SC 13D | 2023-08-21 | Community US Fund Management, Inc. | Gamida Cell Ltd. | 6,169,471 | 5.0% | EDGAR |
| SC 13D/A | 2023-05-26 | NOVARTIS PHARMA AG | Gamida Cell Ltd. | 4,336,759 | 4.1% | EDGAR |
| SC 13G | 2023-05-01 | Stonepine Capital Management, LLC | Gamida Cell Ltd. | 4,743,162 | 4.4% | EDGAR |
| SC 13D/A | 2023-04-25 | AI Gamida Holdings LLC | Gamida Cell Ltd. | 3,750,000 | 3.6% | EDGAR |
| SC 13G | 2023-04-24 | CVI Investments, Inc. | Gamida Cell Ltd. | 7,000,000 | 6.6% | EDGAR |
| SC 13D/A | 2023-04-04 | AI Gamida Holdings LLC | Gamida Cell Ltd. | 3,750,000 | 4.6% | EDGAR |
| SC 13D/A | 2023-03-03 | NOVARTIS PHARMA AG | Gamida Cell Ltd. | 4,336,759 | 5.8% | EDGAR |
| SC 13G | 2023-02-14 | Community US Fund Management, Inc. | Gamida Cell Ltd. | 5,040,329 | 6.8% | EDGAR |
| SC 13G/A | 2023-02-10 | HIGHBRIDGE CAPITAL MANAGEMENT LLC | Gamida Cell Ltd. | 4,222,972 | 5.4% | EDGAR |